Summit Overview

Program Summary

The Society for Immunotherapy of Cancer (SITC) will host the Immunoprevention Virtual Summit on Monday, April 3, from 12–5 p.m. EDT. The summit is a free, public event that features expert panel discussions, invited speakers, and attendee question and answer periods. The multi-stakeholder virtual summit will feature over 25 panelists representing funding agencies, academic researchers, the FDA, and industry.

Register for Free

The SITC Immunoprevention Virtual Summit will highlight the opportunities and limitations in cancer interception and immunoprevention and serve as a platform to advocate for the widespread need for preventative methods and research. Topics to be addressed at the summit include immune environment of prevention, immune diagnostics and prevention, current progress in immunoprevention by cancer type, resources and funding opportunities, and the roles of the FDA, industry, and advocacy in the field of prevention.

*Summit agenda to be posted soon, check back for updates!

Problem Statement

Immune interception and prevention strategies harness the immune system to prevent invasive cancer at a stage when anti-tumor immunity is most effective. Despite its great potential to positively impact public health, there is a marked lack of education and awareness within the field of immuno-oncology on immunoprevention, and the field of cancer interception and prevention remains largely nascent. The scientific community must effectively address and develop the field of immunoprevention, improving patient outcomes and reducing the global burden of cancer. 

Summit Goals & Objectives

The primary objective of the SITC Immunoprevention Virtual Summit is to highlight opportunities and challenges in the field of immunoprevention. Secondary goals include defining immunoprevention, with an emphasis on primary prevention; developing a roadmap to move forward in the field of immunoprevention; and establishing SITC as a home for researchers and healthcare providers interested in immunoprevention.

Summit Organizers

• Leisha Emens, MD, PhD – Co-Chair
  Ankyra Therapeutics
• Sasha Stanton, MD, PhD – Co-Chair
  Providence Cancer Institute / Earle A. Chiles Cancer Research Institute
• Philip Castle, PhD, MPH
  National Cancer Institute
• Mark Cobbold, PhD
  AstraZeneca
• Olivera Finn, PhD
  University of Pittsburgh
• Elizabeth Jaffee, MD, FAIO
  Sidney Kimmel Cancer Center, Johns Hopkins University
• Shizuko Sei, MD
  National Cancer Institute